"Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. Its 7,700 employees are focused on improving the health and well-being of people throughout Wisconsin and Upper Michigan. Aspirus serves communities through four hospitals in Upper Michigan and four hospitals in Wisconsin, more than 50 clinics, home health and hospice care, pharmacies, critical care and air-medical transport, medical goods, nursing homes and a broad network of physicians. Aspirus was recognized by IBM Watson Health as a Top 15 Health System in its 2018 annual study identifying the top-performing health systems in the country."

During the past decade, Aspirus Regional Cancer Center conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 87 clinical trials were completed, i.e. on average, 95.6% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 50 clinical trials were completed. i.e. 122% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aspirus Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 63 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "NRG Oncology" with 14 trials sponsored and "Radiation Therapy Oncology Group" with 14 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aspirus Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 118 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "Cancer and Leukemia Group B" with 8 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Aspirus Regional Cancer Center" are "Breast Cancer" (16 trials), "Colorectal Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Prostate Cancer" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Aspirus Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Aspirus Regional Cancer Center" are "Drug" (152 trials), "Other" (106 trials), "Biological" (72 trials), "Radiation" (50 trials) and "Procedure" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (49 trials), "Questionnaire Administration" (24 trials), "Bevacizumab" (18 trials) and "Paclitaxel" (18 trials). Other intervention names were less common.

The vast majority of trials in "Aspirus Regional Cancer Center" are 140 trials for "All" genders, 34 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Aspirus Regional Cancer Center". undefined are not yet recruiting, 36 are recruiting, 82 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Aspirus Regional Cancer Center, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Aspirus Regional Cancer Center, 2 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 129 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".